NEWLINK GENETICS CORP Note Agreements
5 Contracts & Agreements
- Clinical Trial Funding Agreement, by and among Double Point Ventures LLC and Lumos Pharma, Inc., dated October 22, 2024 (including the form of Note with respect thereto) (Filed With SEC on October 23, 2024)
- PROMISSORY NOTE (Filed With SEC on February 28, 2011)
- PROMISSORY NOTE (Filed With SEC on February 28, 2011)
- PROMISSORY NOTE (Filed With SEC on February 28, 2011)
- PROMISSORY NOTE (Filed With SEC on December 21, 2010)
